Ritalin vs. Qelbree

See how Ritalin and Qelbree compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Ritalin is a stimulant that can work within 30 to 45 minutes, while Qelbree is a nonstimulant that needs several weeks of titration to reach its full effective dose.

  • Both drugs can raise heart rate and blood pressure, so anyone with certain heart conditions needs close monitoring on either medication.

  • Ritalin is a controlled substance with misuse and dependence risks, while Qelbree's main added risk is a boxed warning for suicidal thoughts in children and young adults.

Ritalin vs. Qelbree Drug Summary

Ritalin

Ritalin (methylphenidate) is a central nervous system stimulant approved for ADHD in adults and children 6 and older, and as a second-line option for narcolepsy in adults. The immediate-release tablet is usually taken two to three times a day, 30 to 45 minutes before meals, with the dose adjusted based on response.

Qelbree

Qelbree (viloxazine) is a nonstimulant selective norepinephrine reuptake inhibitor approved for ADHD in adults and children 6 and older. It comes as an extended-release capsule taken once daily, with the dose increased over several weeks to reach an effective level.

Ritalin vs. Qelbree Side Effects

Ritalin

Most common
Headache (up to 14%)
Decreased appetite (up to 8%)
Nausea (up to 13%)
Insomnia (up to 4%)

Qelbree

Most common
Headache (≥5%)
Decreased appetite (≥5%)
Somnolence (up to 16%)
Fatigue (up to 12%)

Ritalin vs. Qelbree Dosage

Ritalin

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 5 mg twice daily At the start
Maximum dose Max 60 mg/day If needed
Dose changes 4 increases As tolerated

Qelbree

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 100 mg once daily Week 1
Maximum dose 600 mg once daily Week 5 onward
Dose changes 4 increases Every week

Ritalin vs. Qelbree Indications

Ritalin

Ritalin is FDA-approved to treat ADHD in adults and children 6 years and older. It is also approved as a second-line treatment for narcolepsy in adults. Some clinicians prescribe it off-label for conditions such as cognitive symptoms after brain injury, though evidence for that use is limited.

  • ADHD in children 6 years and older

  • ADHD in adults

  • Narcolepsy in adults, as a second-line treatment

  • Off-label: cognitive symptoms after traumatic brain injury (not FDA-approved)

Qelbree

Qelbree is FDA-approved to treat ADHD in adults and children 6 years and older. It is not approved for bipolar disorder or major depressive disorder. As a newer nonstimulant, it is sometimes considered for patients who cannot take stimulant medications.

  • ADHD in children and adolescents ages 6 to 17

  • ADHD in adults

  • Not approved for bipolar disorder

  • Not approved for major depressive disorder

Ritalin vs. Qelbree Pros and Cons

Ritalin

Ritalin is a stimulant with decades of clinical use and a dosing schedule that can be fine-tuned in small increments. As a Schedule II controlled substance, it comes with stricter prescribing rules and a higher potential for misuse than nonstimulant options.

Pros

  • Fast-acting: symptom relief can begin within 30 to 45 minutes of a dose

  • Decades of real-world use since FDA approval in 1955, with extensive safety data

  • Dose can be adjusted in small increments to closely match response

  • Generic methylphenidate typically costs $25 to $95 a month without insurance, well below Qelbree's list price

Cons

  • Schedule II controlled substance, so refills come with stricter prescribing rules and misuse risk

  • Immediate-release tablets usually need to be taken two to three times a day

  • Requires regular monitoring of growth, heart rate, and blood pressure

  • Not recommended for patients with certain heart conditions or a family history of tics or Tourette's syndrome

Qelbree

Qelbree is a newer nonstimulant that avoids the controlled-substance restrictions and misuse risk associated with stimulants. Its once-daily dosing is convenient, but it carries a boxed suicidality warning and requires several weeks of titration to reach a full dose.

Pros

  • Not a controlled substance, so it comes with fewer prescribing and refill restrictions

  • Only needs to be taken once a day

  • A nonstimulant option for patients who cannot tolerate or should not take stimulants

  • Capsule can be opened and sprinkled on food for people who have trouble swallowing pills

Cons

  • Carries a boxed warning for increased risk of suicidal thoughts and behavior in children, teens, and young adults

  • Newer medication, approved in 2021, so there is less long-term real-world data than for older stimulants

  • Takes several weeks of titration before reaching a fully effective dose

  • Typically costs $360 to $535 a month without insurance, since no generic version exists yet

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.